Breakthrough in cancer cachexia with Ponsegromab treatment

Hagen Kennecke, Chief health officer of the OHSU Knight-Legacy Health Cancer Collaborative, shared a post by NEJM, on X:

“Possible breakthrough in cancer cachexia with Ponsegromab, anti-GDF 15.

Significant weight gain, especially in patients with colorectal cancer.”

Quoting NEJM’s post:

“Ponsegromab for the Treatment of Cancer Cachexia.

Authors: John D. Groarke, Jeffrey Crawford,  Susie M. Collins,  Shannon Lubaczewski,Eric J. Roeland, Tateaki Naito,  Andrew E. Hendifar,Marie Fallon, Koichi Takayama, Timothy Asmis, Richard F. Dunne,Isik Karahanoglu, Carrie A. Northcott, Magdalena A. Harrington, Michelle Rossulek, Ruolun Qiu , Aditi R. Saxena.“

Source: Hagen Kennecke/X and NEJM/X